Skip to Main Content

Author Details

Robert C Smallridge
Mayo Clinic School of Medicine, Mayo Clinic
1975
207
51
PMIDPaper TitleJournal TitlePublished Year
35668021Anaplastic thyroid cancer: An update.Best Pract Res Clin Endocrinol Metab2023
35668021Anaplastic thyroid cancer: An update.Best Pract Res Clin Endocrinol Metab2023
36283091Evaluating new treatments for anaplastic thyroid cancer.Expert Rev Anticancer Ther2022
36283091Evaluating new treatments for anaplastic thyroid cancer.Expert Rev Anticancer Ther2022
32900277Challenges in Developing Recommendations Based on Low-Quality Evidence in Thyroid Guidelines.Thyroid2021
337289992021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.Thyroid2021
33449369Initial treatment of patients with thyroid cancer: Outcomes and factors associated with care at academic versus nonacademic cancer centers.Cancer2021
34089480Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine use.Endocrine2021
32900277Challenges in Developing Recommendations Based on Low-Quality Evidence in Thyroid Guidelines.Thyroid2021
337289992021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.Thyroid2021
34089480Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine use.Endocrine2021
33449369Initial treatment of patients with thyroid cancer: Outcomes and factors associated with care at academic versus nonacademic cancer centers.Cancer2021
32538690An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer.Thyroid2020
32421817Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy.J Clin Endocrinol Metab2020
32538690An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer.Thyroid2020
32997127Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels.JAMA Netw Open2020
32997127Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels.JAMA Netw Open2020
32421817Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy.J Clin Endocrinol Metab2020
31036352Comparison of Incident Cardiovascular Event Rates Between Generic and Brand l-Thyroxine for the Treatment of Hypothyroidism.Mayo Clin Proc2019
31798211Ethanol Ablation of Neck Metastases from Differentiated Thyroid Carcinoma.Semin Intervent Radiol2019
31036352Comparison of Incident Cardiovascular Event Rates Between Generic and Brand l-Thyroxine for the Treatment of Hypothyroidism.Mayo Clin Proc2019
30737244Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies.Clin Cancer Res2019
30707227Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer.JAMA Netw Open2019
31798211Ethanol Ablation of Neck Metastases from Differentiated Thyroid Carcinoma.Semin Intervent Radiol2019
30707227Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer.JAMA Netw Open2019
30737244Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies.Clin Cancer Res2019
29443941Cytokeratin-8 in Anaplastic Thyroid Carcinoma: More Than a Simple Structural Cytoskeletal Protein.Int J Mol Sci2018
30545990NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.J Natl Compr Canc Netw2018
30084677ThyroSeq<sup>®</sup>V2.0 Molecular Testing: A Cost-Effective Approach for the Evaluation of Indeterminate Thyroid Nodules.Endocr Pract2018
29443941Cytokeratin-8 in Anaplastic Thyroid Carcinoma: More Than a Simple Structural Cytoskeletal Protein.Int J Mol Sci2018
29846633Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts.J Clin Endocrinol Metab2018
29846633Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts.J Clin Endocrinol Metab2018
30084677ThyroSeq<sup>®</sup>V2.0 Molecular Testing: A Cost-Effective Approach for the Evaluation of Indeterminate Thyroid Nodules.Endocr Pract2018
30545990NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.J Natl Compr Canc Netw2018
27796151Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma.Thyroid2017
28975018Comprehensive Genomic Profiling of a Rare Thyroid Follicular Dendritic Cell Sarcoma.Rare Tumors2017
29029287Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer.J Clin Endocrinol Metab2017
28253395Rapidly Enlarging Thyroid Mass in a Patient With History of Multiple Cancers.JAMA Oncol2017
27796151Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma.Thyroid2017
28253395Rapidly Enlarging Thyroid Mass in a Patient With History of Multiple Cancers.JAMA Oncol2017
29029287Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer.J Clin Endocrinol Metab2017
28975018Comprehensive Genomic Profiling of a Rare Thyroid Follicular Dendritic Cell Sarcoma.Rare Tumors2017
27074952Improving the adoption of thyroid cancer clinical practice guidelines.Laryngoscope2016
30058930Unravelling the best combination of therapies to treat anaplastic thyroid cancer.Expert Rev Endocrinol Metab2016
26799628ACTIVE SURVEILLANCE FOR PAPILLARY THYROID MICROCARCINOMA: NEW CHALLENGES AND OPPORTUNITIES FOR THE HEALTH CARE SYSTEM.Endocr Pract2016
27074952Improving the adoption of thyroid cancer clinical practice guidelines.Laryngoscope2016
26602598A Century of Hyperthyroidism at Mayo Clinic.Mayo Clin Proc2016
30058930Unravelling the best combination of therapies to treat anaplastic thyroid cancer.Expert Rev Endocrinol Metab2016
26602598A Century of Hyperthyroidism at Mayo Clinic.Mayo Clin Proc2016
26799628ACTIVE SURVEILLANCE FOR PAPILLARY THYROID MICROCARCINOMA: NEW CHALLENGES AND OPPORTUNITIES FOR THE HEALTH CARE SYSTEM.Endocr Pract2016
  • 1 - 50 of 414

Recommended Authors

Jocelyn F Burke
Kirk Kerkorian School of Medicine of University of Nevada
Career Start Year 2002
Number of shared co-authors 0
Anne R Cappola
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 2
Andrew J Bauer
Children's Hospital of Philadelphia
Career Start Year 1998
Number of shared co-authors 2
Richard T Kloos
Veracyte Inc.
Career Start Year 1995
Number of shared co-authors 5
Dhaval Patel
National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 15
Andrea Hofmann
Institute of Human Genetics, University of Bonn and Department of Genomics
Career Start Year 1991
Number of shared co-authors 0
Mark Gurnell
Wellcome-MRC Institute of Metabolic Science and Addenbrooke's Hospital
Career Start Year 1990
Number of shared co-authors 0
Yaron Tomer
Meyer Cancer Center
Career Start Year 1987
Number of shared co-authors 1
Lisa U Pascual
Orthopaedic Trauma Institute, University of California san francisco
Career Start Year 1987
Number of shared co-authors 0
Fred C G J Sweep
Radboud University Medical Centre
Career Start Year 1987
Number of shared co-authors 0
Eric P Smith
University of Cincinnati College of Medicine
Career Start Year 1986
Number of shared co-authors 0
Cuong Hoang-Vu
Center for Cancer Research, National Cancer Institute
Career Start Year 1985
Number of shared co-authors 4
Gilbert J Cote
The University of Texas MD Anderson Cancer Center Houston
Career Start Year 1983
Number of shared co-authors 6
Graham R Williams
Imperial College London Hammersmith Hospital London UK.
Career Start Year 1983
Number of shared co-authors 2
Elzbieta Stachlewska
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Career Start Year 1982
Number of shared co-authors 2
David M Thomas
Garvan Institute of Medical Research
Career Start Year 1980
Number of shared co-authors 2
Shereen Ezzat
University of Toronto
Career Start Year 1979
Number of shared co-authors 1
Ludwig Wagner
Child and Family Research Institute, University of British Columbia
Career Start Year 1979
Number of shared co-authors 0
Jonathan A Pachter
Laufer Center for Physical and Quantitative Biology, Stony Brook University
Career Start Year 1979
Number of shared co-authors 0
Luca Chiovato
University of Pavia
Career Start Year 1978
Number of shared co-authors 0
Barbara Jarzab
M. Sklodowska-Curie National Research Institute of Oncology Gliwice Branch
Career Start Year 1976
Number of shared co-authors 5
Terry F Davies
Thyroid Research Unit, Icahn School of Medicine at Mount Sinai
Career Start Year 1975
Number of shared co-authors 1
Robert F Gagel
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 5
George G Klee
Mayo Clinic
Career Start Year 1974
Number of shared co-authors 3
Judith D Goldberg
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 0
Stephen J Marx
National Institutes of Digestive Disease and Kidney, National Institutes of Health
Career Start Year 1971
Number of shared co-authors 9
Peter J Dempsey
University of Colorado
Career Start Year 1968
Number of shared co-authors 0
Sheue-Yann Cheng
National Cancer Institute, National Institutes of Health
Career Start Year 1967
Number of shared co-authors 10
Peter J Snyder
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1965
Number of shared co-authors 1
Gopal Krishna
ICAR-Central Institute of Fisheries Education
Career Start Year 1964
Number of shared co-authors 0

Collaborators

John A Copland
Mayo Clinic Jacksonville
Co-authored papers 24
Vera J Suman
Mayo Clinic
Co-authored papers 8
Clive S Grant
Inova Health System
Co-authored papers 7
Robert L Foote
Mayo Clinic
Co-authored papers 6
Motoyasu Saji
The Ohio State University School of Medicine
Co-authored papers 5
Electron Kebebew
Stanford University School of Medicine
Co-authored papers 5
Peter Kopp
University of Lausanne
Co-authored papers 3
William H Westra
Icahn School of Medicine at Mount Sinai Hospital.
Co-authored papers 3
Matthew D Ringel
The Ohio State University College of Medicine and Comprehensive Cancer Center
Co-authored papers 2
Nilay D Shah
Mayo Clinic
Co-authored papers 2
Stephen B Baylin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Co-authored papers 2
Robert I Haddad
Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 2
Richard W Joseph
Mayo Clinic Hospital
Co-authored papers 2
Lisa Zhang
National Institute of Child Health and Development
Co-authored papers 2
Susan R Davis
Co-authored papers 2
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 2
Myriem Boufraqech
The University of Texas at Austin
Co-authored papers 2
Fouad Kandeel
Co-authored papers 2
Amit Mehta
Center for Cancer Research, Maryland. Geisel School of Medicine at Dartmouth
Co-authored papers 2
Joseph S Ross
Yale School of Medicine
Co-authored papers 2
Yan W Asmann
Mayo Clinic
Co-authored papers 2
Julia E Crook
Center for Clinical and Translational Science, Mayo Clinic
Co-authored papers 2
Xiaoxi Yao
Department of Cardiovascular Medicine Mayo Clinic Rochester MN.
Co-authored papers 2
Paul C Carpenter
Mayo Clinic College of Medicine, Mayo Clinic
Co-authored papers 1
Mei He
Sichuan University
Co-authored papers 1
Neill R Graff-Radford
Mayo Clinic Florida
Co-authored papers 1
Naris Nilubol
Center for Cancer Research
Co-authored papers 1
Marco A Marra
University of British Columbia
Co-authored papers 1
Jing Wang
Co-authored papers 1
John M Koomen
Co-authored papers 1
Release 1.2